Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2000
07/27/2000CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
07/27/2000CA2356642A1 Improved phytases
07/27/2000CA2354375A1 Compositions and methods for the diagnosis and treatment of tumor
07/27/2000CA2294572A1 Genetic compositions and methods
07/26/2000EP1022340A1 Stabilisation of compositions comprising non-viral nucleic acid transfer compositions
07/26/2000EP1022339A1 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
07/26/2000EP1022338A2 Viral vaccines
07/26/2000EP1022337A2 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
07/26/2000EP1022336A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM
07/26/2000EP1022335A1 High-throughput screening of gene function using libraries for functional genomics applications
07/26/2000EP1022334A2 Novel amylases
07/26/2000EP1022333A1 Human tumor suppressor gene
07/26/2000EP1022332A1 Beta-fructofuranosidase and gene thereof
07/26/2000EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
07/26/2000EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
07/26/2000EP1022286A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH
07/26/2000EP1022285A1 Oxidation-resistant ribonuclease inhibitor
07/26/2000EP1021725A1 Early detection of lysosomal storage disorders
07/26/2000EP1021717A1 Method of sorting birds in ovo
07/26/2000EP1021713A2 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination
07/26/2000EP1021562A1 Multiple displacement amplification
07/26/2000EP1021561A1 $g(b)-ADRENERGIC RECEPTOR POLYMORPHISMS
07/26/2000EP1021560A1 Antimicrobial drug screening using a recombinant cell comprising a rna-dependent amidotransferase gene
07/26/2000EP1021559A2 Method and kit for amplification, sequencing and typing of classical hla class i genes
07/26/2000EP1021555A1 STABILIZATION OF $i(HELICOBACTER) UREASE
07/26/2000EP1021554A1 Analyte assay using particulate labels
07/26/2000EP1021553A2 Eukaryotic gene expression cassette and uses thereof
07/26/2000EP1021552A1 Transgenic lemnaceae
07/26/2000EP1021551A1 Plant fatty acid hydroxylase genes
07/26/2000EP1021550A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work
07/26/2000EP1021549A2 SENSE mRNA THERAPY
07/26/2000EP1021548A1 Method for introducing and expressing rna in animal cells
07/26/2000EP1021547A1 Papilloma virus capsomere vaccine formulations and methods of use
07/26/2000EP1021546A1 Neutral sphingomyelinase
07/26/2000EP1021544A2 Chimeric vaccine against tick-borne encephalitis virus
07/26/2000EP1021543A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit
07/26/2000EP1021542A1 Apo-3 ligand
07/26/2000EP1021541A1 Amino-terminally truncated mcp-2 as chemokine antagonists
07/26/2000EP1021540A1 Human progesterone receptor complex p23-like protein
07/26/2000EP1021539A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells
07/26/2000EP1021538A1 Yeast cells expressing modified g proteins and methods of use therefor
07/26/2000EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor
07/26/2000EP1021536A2 Mammalian genes involved in viral infection and tumor suppression
07/26/2000EP1021535A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same
07/26/2000EP1021534A1 Hepatitis c receptor protein cd81
07/26/2000EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins
07/26/2000EP1021532A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
07/26/2000EP1021531A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
07/26/2000EP1021530A1 PROTEINS ALIKE TO HUMAN COMPLEMENT FACTOR H AND cDNAs ENCODING THESE PROTEINS
07/26/2000EP1021529A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS
07/26/2000EP1021528A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents
07/26/2000EP1021527A1 Plant and viral promoters
07/26/2000EP1021526A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV
07/26/2000EP1021465A2 Gfp-annexin fusion proteins
07/26/2000EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
07/26/2000EP1021460A1 Laminins and uses thereof
07/26/2000EP1021202A1 Immunogenic peptides from the hpv e7 protein
07/26/2000EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
07/26/2000EP1021092A4 Food products containing structured triglycerides
07/26/2000EP1021092A1 Food products containing structured triglycerides
07/26/2000EP1021080A1 Coat protein mediated resistance in plants
07/26/2000EP1007964A4 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES
07/26/2000EP0992577B1 Process for microinjection and nanopipette for introducing an injection product, particularly foreign genetic material in procaryotic or eucaryotic cells or cellcomparments thereof (plastides, cell nucleus)
07/26/2000EP0904541A4 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA)
07/26/2000EP0870063B1 Fluorescence detection assay for homogeneous pcr hybridization systems
07/26/2000EP0832134B1 Anti-allergy bispecific molecules
07/26/2000EP0828752A4 Chitotriosidase
07/26/2000EP0786084A4 Method for screening compositions
07/26/2000EP0769054B1 Immunomodulators
07/26/2000EP0755458A4 Electrogenerated chemiluminescence labels for analysis and/or referencing
07/26/2000EP0629293B1 Assay for adrenal autoantibodies
07/26/2000CN1261407A Method based on use of bacteriophages for detection hiological molecules in biological samples
07/26/2000CN1261406A Reverse transcription method
07/26/2000CN1261404A Lentivirus-Based gene transfer vectors.
07/26/2000CN1261403A Surface exposed proteins from chlamydia pneumoniae
07/26/2000CN1261402A Plant and viral promotors
07/26/2000CN1261400A Laundry and cleaning compositions containing xyloglucanase enzymes
07/26/2000CN1261373A Compositions and methods for activating genes of interest
07/26/2000CN1261281A Peptide parathyroid hormone analogs
07/26/2000CN1261105A Human gene pRb-BP125 reacting on anticancer gene coding resultant pRB
07/26/2000CN1261104A Human oxido-reductase subunit and its coding sequence, preparing process and application
07/26/2000CN1261103A Human targeting glycogen protein,and its coding sequence, preparing process and application
07/26/2000CN1261102A Human spindle protein and its coding sequence, preparing process and application
07/26/2000CN1261101A Method for dwarfing plants
07/26/2000CN1261075A Recombination virus able to specifically kill tumor cells associated with EB virus and building process
07/26/2000CN1260998A Recombination adenovirus and its application in tumor treatment
07/26/2000CN1054881C New type recombinant DNA containing luciferase gene and production method of luciferase
07/25/2000US6093874 Methods for improving seeds
07/25/2000US6093873 Genetically engineered mice containing alterations in the gene encoding RXR
07/25/2000US6093872 Human fetal liver tissue and human fetal thymus is introduced into a vascularized site of an immunocompromised mouse at a site supplied with a vascular system; the fetal tissue results in formation of functional human bone marrow tissue
07/25/2000US6093811 Oligonucleotide modulation of cell adhesion
07/25/2000US6093810 Nematode-induced genes in tomato
07/25/2000US6093809 Nucleotide sequence; anticarcinogenic and antiaging agents; diagnostic applications; evolutionary (e.g., phylogenetic) investigations
07/25/2000US6093808 IκBEGFP constructs, cell lines and methods of use
07/25/2000US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage
07/25/2000US6093800 Amino acid sequence of cell surface protein; diagnostic markers of cancer, including hormone refractory prostate cancer; anticarcinogenic agents
07/25/2000US6093796 Recombinant hK2 polypeptide
07/25/2000US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells
07/25/2000US6093700 Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF
07/25/2000US6093695 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP